1eax: Difference between revisions

The type II transmembrane multidomain serine proteinase MT-SP1/matriptase, is highly expressed in many human cancer-derived cell lines and has been, implicated in extracellular matrix re-modeling, tumor growth, and, metastasis. We have expressed the catalytic domain of MT-SP1 and solved, the crystal structures of complexes with benzamidine at 1.3 A and bovine, pancreatic trypsin inhibitor at 2.9 A. MT-SP1 exhibits a trypsin-like, serine proteinase fold, featuring a unique nine-residue 60-insertion loop, that influences interactions with protein substrates. The structure, discloses a trypsin-like S1 pocket, a small hydrophobic S2 subsite, and an, open negatively charged S4 cavity that favors the binding of basic P3/P4, residues. A complementary charge pattern on the surface opposite the, active site cleft suggests a distinct docking of the preceding low density, lipoprotein receptor class A domain. The benzamidine crystals possess a, freely accessible active site and are hence well suited for soaking small, molecules, facilitating the improvement of inhibitors. The crystal, structure of the MT-SP1 complex with bovine pancreatic trypsin inhibitor, serves as a model for hepatocyte growth factor activator inhibitor 1, the, physiological inhibitor of MT-SP1, and suggests determinants for the, substrate specificity.

1EAX is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with SO4 and BEN as [http://en.wikipedia.org/wiki/ligands ligands]. Structure known Active Site: SO4. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1EAX OCA].  

''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov  5 13:05:19 2007''